Skip to main content
ANAB logo

AnaptysBio, Inc.

ANABNASDAQHealthcareBiotechnology

$50.50Today:- (-)1Y +41.47%

As of Oct 28, 2026 close

Market cap
$1.82B
P/E (TTM)
9.28
Forward P/E
-
Dividend yield
-
52-week range
$30.27$73.30
Volume (live)
-
Avg. volume (3M)
560.81K

AnaptysBio (ANAB) Financial Ratios

For fiscal 2026 (fiscal year ended Jun 30, 2026), AnaptysBio had a P/E ratio of 7.63, debt-to-equity of 25.47 (up from 7.81) and a current ratio of 5.61 (down from 9.07). A current ratio of 5.61 means current assets exceed current liabilities.

AnaptysBio Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingJun 2026Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio7.63------
Forward P/E37.9014.6814.6814.6814.6816.86-
P/S Ratio18.845.724.4133.1885.6515.217.84
P/B Ratio188.8136.085.686.463.362.691.48
Price/Tangible Book188.8136.085.686.463.362.691.48
Price/FCF-68.15-----
Price/OCF-68.15-----
Enterprise Value Ratios
EV/Revenue18.756.143.7228.3173.849.623.34
EV/EBITDA30.276.345.13----
EV/EBIT30.286.355.14----
EV/FCF-73.10-----
Profitability & Returns
Return on Equity (ROE)-298.86%38.98%-93.44%-41.62%-15.35%-4.97%
Return on Assets (ROA)-33.44%8.83%-18.47%-11.48%-6.70%-3.50%
Return on Invested Capital (ROIC)56.58%166.55%72.82%-184.20%-102.31%--
Return on Capital Employed (ROCE)23.30%69.70%15.10%-37.90%-19.70%-9.10%-6.00%
Leverage & Solvency Ratios
Debt/Equity25.477.815.213.731.240.760.00
Debt/EBITDA4.101.275.38----
Debt/FCF-14.76-----
Liquidity Ratios
Current Ratio5.619.079.5110.8717.1634.4020.01
Quick Ratio5.546.367.1810.6216.9934.1019.86
Efficiency Ratios
Asset Turnover-0.550.200.030.020.120.18
Yield & Distribution Ratios
Earnings Yield13.11%-0.99%-36.05%-28.74%-14.61%-6.02%-3.39%
FCF Yield-5.26%1.47%-33.59%-21.36%-8.39%-4.92%-2.50%
Buyback Yield-23.96%-2.33%-9.73%4.41%-2.68%-0.47%-0.90%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AnaptysBio Financial Ratios

What is AnaptysBio's P/E ratio?

AnaptysBio's P/E ratio was 7.63 for fiscal 2026 (period ended Jun 30, 2026).

What is AnaptysBio's debt-to-equity ratio?

AnaptysBio's debt-to-equity ratio was 25.47 for fiscal 2026 (period ended Jun 30, 2026). It was 7.81 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition